According to newly released federal data, sales of medically important antimicrobials used in food-producing animals in the U.S. increased by 3 percent in 2014 and by 23 percent between 2009 and 2014. The U.S. Food and Drug Administration (FDA) has released its summary of the information animal drug sponsors are required by the Animal Drug User Fee Act (ADUFA) to report every year. In 2014, domestic sales and distribution of medically important antimicrobials accounted for 62 percent of all antimicrobials approved for use in food animals. Tetracyclines accounted for 70 percent of these sales, penicillins for 9 percent, macrolides for 7 percent, sulfas for 5 percent, aminoglycosides for 3 percent, lincosamides for 2 percent, and cephalosporins and fluoroquinolones for less than 1 percent each. The 2014 findings reflect an ongoing trend, with rates of increase nearly the same as in 2013. An ongoing issue with the ADUFA data for public health is that sales and distribution information is not directly correlated with how the drugs are actually used. In October, FDA, the U.S. Department of Agriculture and the U.S. Centers for Disease Control and Prevention held a public meeting to discuss possible approaches for collecting additional on-farm antimicrobial drug use and resistance data. (To sign up for a free subscription to Food Safety News, click here.)
The News Desk team at Food Safety News covers breaking developments, regulatory updates, recalls, and key topics shaping food safety today. These articles are produced collaboratively by our editorial staff.
A leading academic has warned that any plans for UK regulators to help industry grow could end up repeating past mistakes and impacting public health.
As part of modernization plans,
The rate of poultry flocks positive for Campylobacter in Norway went up in 2025 to almost 5 percent.
Overall, 99 broiler flocks tested positive for Campylobacter among all flocks slaughtered
The number of Listeria infections reached a new high in 2025 in Norway but Salmonella cases fell sharply.
An annual report from the Norwegian Institute of Public Health (FHI) shows
The a2 Milk Company (“a2MC”) has recalled three specific batches of its imported a2 Platinum Premium USA label infant formula 0-12 months because of the presence of cereulide. The product
JXK Enterprises Inc. is recalling Boner Bears Chocolate, Lot #BB21125, after being notified that FDA laboratory analysis confirmed the presence of sildenafil, an active ingredient in the FDA-approved prescription drug
Total Nutrition Inc. of Deer Park, NY, is recalling TNVitamins Ultra Potent Complete Green Superfood and Doctor’s Pride Complete Green Superfood Ultra Potent Moringa Capsules because they have the
Bazzini LLC, of Allentown, PA, a co-manufacturer utilized by SkinnyDipped, is recalling a limited number of cases of SkinnyDipped Dark Chocolate Coconut Almond Bites, because of the possible presence of